Evidence map›Paper›PMID 35719805›Full record

ArticleCureus2022

Proportion of New Onset of Anosmia and Its Diagnostic Significance in COVID-19.

Ripu Daman Arora, Kota Sesha Brahma Sree Krishna Sasanka, Pugazhenthan Thangaraju, Sree Sudha Tanguturi Yella, Nitin M Nagarkar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ripu Daman AroraOtorhinolaryngology-Head and Neck Surgery (ENT-HNS), All India Institute of Medical Sciences, Raipur, IND.
Kota Sesha Brahma Sree Krishna SasankaOtorhinolaryngology-Head and Neck Surgery (ENT-HNS), All India Institute of Medical Sciences, Deoghar, IND.
Pugazhenthan ThangarajuPharmacology and Therapeutics, All India Institute of Medical Sciences, Raipur, IND.
Sree Sudha Tanguturi YellaPharmacology, All India Institute of Medical Sciences, Deoghar, IND.
Nitin M NagarkarOtorhinolaryngology-Head and Neck Surgery (ENT-HNS), All India Institute of Medical Sciences, Raipur, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to know the proportion of new-onset of anosmia and to find its diagnostic significance in coronavirus disease 2019 (COVID-19) patients attending the hospital. Study design and duration: The Indian smell test in COVID-19 by AIIMS Raipur (ISCA-R) was developed for evaluating olfaction in the Indian population. The olfactory function was assessed using the corona scale on anosmia AIIMS Raipur (COSANAr).

resultsOut of 256 patients, 171 were males and 85 were females. In the majority of the patients, 75 (29.29%), the COSANAr score "0" was higher on the day of admission compared to the score "3" on the day of discharge with 61 (23.82%) patients. There was no improvement in 134 (52.34%) patients with loss of smell at the time of discharge.

conclusionThis study is a step forward in identifying anosmia by ISCA-R at the early stages of the COVID phase. The COSANAr is affordable for the Indian population. It is noticed that most of the patients have mild hyposmia at the time of discharge and anosmia at the admission time.

Indexed as

anosmiacosanar (corana scale on anosmia aiims raipur) scalecovid-19hyposmiaisca-r (indian smell test in covid by aiims raipur)loss of smellolfactory dysfunction

Identifiers

PMID35719805
PMCPMC9191271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.